Search

Sadik Esener, Ph.D., and Brian Druker, M.D., at Knight Cancer Institute

March 22, 2024

Steven Mansoor, M.D., Ph.D.

March 21, 2024

Steven Mansoor, M.D., Ph.D., and colleagues have identified the inner workings of the P2X7 protein receptor, which is associated with inflammation, coronary artery disease, cancer, multiple sclerosis and more. (OHSU)

OHSU Match Day 2024: A career-defining moment for soon-to-be physicians

March 15, 2024

M.D. Class of 2024 achieves a 99% placement rate; OHSU residency programs post 99% fill rate.

Match Day de OHSU 2024: un momento decisivo para la carrera de los futuros médicos

March 15, 2024

La clase de Doctores en Medicina de 2024 logra una tasa de colocación del 99%; los programas de residencia de OHSU alcanzan una tasa de ocupación del 99%.

OHSU Knight Cancer Institute announces leadership transition

March 14, 2024

Amid continued growth, longtime director Brian Druker, M.D., will become CEO; Tom Sellers, Ph.D., M.P.H., will take on director role.

Research sheds light on new strategy to treat infertility

March 08, 2024

OHSU scientists advance technique to turn a skin cell into an egg; could help same-sex couples, others have children genetically related to both parents.

OHSU ofrece un nuevo tratamiento para un tipo mortal de cáncer de piel

March 07, 2024

Dr. Richard Maziarz, director médico del programa de trasplante de adultos de células madre y sangre y terapia celular en OHSU Knight Cancer Institute. Los investigadores del programa están buscando nuevas formas de tratar cánceres letales como el cáncer de piel. (OHSU/Kristyna Wentz-Graff)

OHSU offers new treatment for deadly skin cancer

Search

OHSU in the News